The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
出版年份 2013 全文链接
标题
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
作者
关键词
-
出版物
Diabetes & Vascular Disease Research
Volume 10, Issue 4, Pages 353-360
出版商
SAGE Publications
发表日期
2013-05-15
DOI
10.1177/1479164113481817
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GLP-1 Receptor Agonists: Effects on Cardiovascular Risk Reduction
- (2012) Daniel Lorber Cardiovascular Therapeutics
- The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights
- (2012) Rishi Puri et al. Current Diabetes Reports
- An overview of the pharmacokinetics, efficacy and safety of liraglutide
- (2012) Bruce Bode DIABETES RESEARCH AND CLINICAL PRACTICE
- Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice
- (2012) F. Vittone et al. DIABETOLOGIA
- Liraglutide prevents diabetes progression in prediabetic OLETF rats
- (2012) Nanjing Guo et al. ENDOCRINE JOURNAL
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Treatment evaluation of liraglutide in type 2 diabetes
- (2012) Ram Kela et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
- (2011) M. Nagashima et al. DIABETOLOGIA
- DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
- (2011) Nga N Ta et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice
- (2011) Corinne A Schuyler et al. JOURNAL OF ENDOCRINOLOGY
- Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging
- (2011) Silvana S Meyrelles et al. Lipids in Health and Disease
- Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product–receptor axis
- (2011) Takanori Matsui et al. PHARMACOLOGICAL RESEARCH
- Stabilisation of atherosclerotic plaques
- (2011) Jacob Fog Bentzon et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
- (2010) Y. Hattori et al. DIABETOLOGIA
- The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture
- (2010) Andrew R. Bond et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
- (2010) Gina J. Ryan et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Current Status and Future Prospects
- (2010) Scott R Drab PHARMACOTHERAPY
- A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
- (2009) Hongbin Liu et al. JOURNAL OF ENDOCRINOLOGY
- Exendin-(9–39) Corrects Fasting Hypoglycemia inSUR-1–/–Mice by Lowering cAMP in Pancreatic β-Cells and Inhibiting Insulin Secretion
- (2008) Diva D. De León et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search